News
In February 2025, Belite completed a registered direct offering priced at the market, raising gross proceeds of $15 million, ...
KIVI Boise, ID on MSN2h
Boise residents raise concerns over six-story apartment complex developmentPoland-based Volonaut has revealed their Airbike: a small one-person vehicle said to be able to fly at 124 mph. Supreme Court Chief Justice Roberts said that "people have a misunderstanding about how ...
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
Supplementing with B vitamins and the essential nutrient choline may help slow the progression of glaucoma, a new study in ...
High-resolution fluorescent sensor can visualize intracellular adenosine dynamics at multiple scales
A research team has published a study in Nature Communications detailing the development of a novel genetically encoded ...
Wa, (UW/R), May 13, GNA – Mr Alexander Sefa, the National Director of the Department of Children (DoC), has urged the public ...
Clinical Trials at the Summit will be held Saturday, June 21, at Fontainebleau Las Vegas. The meeting will focus on the ...
Pat Williams found what he believed was the perfect site to build a stadium in 35 acres of wooded land next to Aquatica, used ...
RWC 2025: Katherine Talcott, MD, discusses the potential connection of auto-immune conditions to AMD
Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...
Lineage Cell Therapeutics, Inc.’s LCTX share price has dipped by 6.64%, which has investors questioning if this is right time to buy.
A vitamin supplement that improves metabolism in the eye appears to slow down damage to the optic nerve in glaucoma. The researchers behind the study have now started a clinical trial on patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results